{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:29:32Z","timestamp":1788715772876,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.yrtph.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T22:03:43Z","timestamp":1452290623000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Assessing Natural Product\u2013Drug Interactions: An End-to-End Safety Framework"],"prefix":"10.1016","volume":"76","author":[{"given":"Amy L.","family":"Roe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Paine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill J.","family":"Gurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1947-2828","authenticated-orcid":false,"given":"James C.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2016.01.004_bib1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/dmd.108.024638","article-title":"Characterization of sandwich-cultured hepatocytes as an in\u00a0vitro model to assess the hepatobiliary disposition of copper","volume":"37","author":"Ansede","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.yrtph.2016.01.004_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2006.10.001","article-title":"Current perspectives in dissolution testing of conventional and novel dosage forms","volume":"328","author":"Azarmi","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.yrtph.2016.01.004_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa053085","article-title":"Saw palmetto for benign prostatic hyperplasia","volume":"354","author":"Bent","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.yrtph.2016.01.004_bib4","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.279.23.1900","article-title":"Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial","volume":"279","author":"Berthold","year":"1998","journal-title":"JAMA."},{"issue":"3","key":"10.1016\/j.yrtph.2016.01.004_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1124\/dmd.113.055236","article-title":"Herb-drug interactions: challenges and oppurtunities for improved predictions","volume":"42","author":"Brantley","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"9","key":"10.1016\/j.yrtph.2016.01.004_bib6","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1124\/dmd.113.052563","article-title":"A\u00a0systematic approach to evaluate herb-drug interaction mechanisms: Investigation of milk thistle extracts and eight isolated constitiuents as CYP3A inhibitors","volume":"41","author":"Brantley","year":"2013","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.yrtph.2016.01.004_bib7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1124\/jpet.109.161927","article-title":"Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations","volume":"332","author":"Brantley","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2016.01.004_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/clpt.2013.78","article-title":"Intracellular drug concentrations and transporters: measurement, modeling, and implications for thel","volume":"94","author":"Chu","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.yrtph.2016.01.004_bib9","first-page":"100","article-title":"Herbal medicine in the management and treatment of HIV-AIDS: a review of clinical trials","volume":"26","author":"Cichello","year":"2014","journal-title":"Aust. J. Herb. Med."},{"key":"10.1016\/j.yrtph.2016.01.004_bib10","series-title":"The Dietary Supplement Consumer. The CRN Consumer Survey on Dietary Supplements","author":"Council for Responsible Nutrition (CRN)","year":"2014"},{"issue":"2","key":"10.1016\/j.yrtph.2016.01.004_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.archger.2014.06.002","article-title":"Use of herbal medicines by elderly patients: a systematic review","volume":"59","author":"de Souza Silva","year":"2014","journal-title":"Arch. Gerontol. Geriat."},{"key":"10.1016\/j.yrtph.2016.01.004_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1472-6882-13-295","article-title":"The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study","volume":"13","author":"Djuv","year":"2013","journal-title":"BMC Complementary Altern. Med."},{"key":"10.1016\/j.yrtph.2016.01.004_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14227\/DT210314P6","article-title":"Evolution of dissolution media over the last twenty years","volume":"21","author":"Dressman","year":"2014","journal-title":"Dissolution Technol."},{"key":"10.1016\/j.yrtph.2016.01.004_bib14","series-title":"Guideline on the Investigation of Drug Interactions","first-page":"1","author":"European Medicines Agency","year":"2012"},{"key":"10.1016\/j.yrtph.2016.01.004_bib15","first-page":"1","article-title":"Concomitant dietary supplement and prescription medication use is prevalent among US adults with doctor-informed medical conditions","author":"Farina","year":"2014","journal-title":"J.\u00a0Acad. Nutr. Dietetics"},{"issue":"9","key":"10.1016\/j.yrtph.2016.01.004_bib16","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1124\/dmd.115.065086","article-title":"Milk thistle constituents inhibit raloxifene intestinal glucuronidation: a potential clinically relevant natural product-drug interaction","volume":"43","author":"Gufford","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.yrtph.2016.01.004_bib17","series-title":"Predicting Pharmacokinetic Herb-drug Interactions: Overcoming Hurdles that Extend beyond Drug-drug Interactions","first-page":"19","author":"Gufford","year":"2014"},{"key":"10.1016\/j.yrtph.2016.01.004_bib18","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1055\/s-0031-1298331","article-title":"Pharmacokinetic herb-drug interactions (Part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance","volume":"78","author":"Gurley","year":"2012","journal-title":"Planta Med."},{"key":"10.1016\/j.yrtph.2016.01.004_bib19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/clpt.2011.51","article-title":"Emerging technologies for improving phytochemical bioavailability: benefits and risks","volume":"89","author":"Gurley","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"13","key":"10.1016\/j.yrtph.2016.01.004_bib20","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1055\/s-0031-1298273","article-title":"Pharmacokinetic herb-drug interactions (part 1): origins, mechanisms, and the impact of botanical dietary supplements","volume":"78","author":"Gurley","year":"2012","journal-title":"Planta Med."},{"issue":"3","key":"10.1016\/j.yrtph.2016.01.004_bib21","article-title":"Suspected interaction between Ginkgo biloba and efavirenz","volume":"24","author":"Health Canada","year":"2014","journal-title":"Can. Adverse React. Newsl."},{"key":"10.1016\/j.yrtph.2016.01.004_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.taap.2009.12.005","article-title":"Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment","volume":"243","author":"Jordan","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2016.01.004_bib23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/jama.2014.17145","article-title":"Echinacea for preventing and treating the common cold","volume":"313","author":"Karsh-V\u00f6lk","year":"2015","journal-title":"JAMA."},{"key":"10.1016\/j.yrtph.2016.01.004_bib24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1124\/dmd.111.044289","article-title":"Models to predict unbound intracellular drug concentrations in the presence of transporters","volume":"40","author":"Korzekwa","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"13","key":"10.1016\/j.yrtph.2016.01.004_bib25","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1055\/s-0032-1315025","article-title":"Limitations of in\u00a0vitro assessments of the drug interaction potential of botanical supplements","volume":"78","author":"Markowitz","year":"2012","journal-title":"Planta Med."},{"key":"10.1016\/j.yrtph.2016.01.004_bib26","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.2012.28733","volume":"308","author":"Mozaffarian","year":"2012","journal-title":"JAMA."},{"key":"10.1016\/j.yrtph.2016.01.004_bib27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pharmtox-011613-140021","article-title":"Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobiotics","volume":"54","author":"Pfeifer","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.yrtph.2016.01.004_bib28","article-title":"A\u00a0top hospital opens up to Chinese herbs as medicines. Evidence is lacking that herbs are effective","author":"Reddy","year":"2014","journal-title":"Wall Str. J."},{"key":"10.1016\/j.yrtph.2016.01.004_bib29","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.285.15.1978","article-title":"Effectiveness of St. John's wort in major depression: a randomized controlled trial","volume":"285","author":"Shelton","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.yrtph.2016.01.004_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/11597910-000000000-00000","article-title":"Drug interactions with herbal medicines","volume":"51","author":"Shi","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.yrtph.2016.01.004_bib31","first-page":"52","article-title":"Herbal dietary supplement sales in US increase 6.8% in 2014","volume":"207","author":"Smith","year":"2015","journal-title":"HerbalGram"},{"key":"10.1016\/j.yrtph.2016.01.004_bib32","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.2009.1913","article-title":"Ginkgo biloba for preventing cognitivedecline in older adults: a randomized trial","volume":"302","author":"Snitz","year":"2009","journal-title":"JAMA."},{"issue":"6","key":"10.1016\/j.yrtph.2016.01.004_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/dmd.32.6.587","article-title":"Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases","volume":"32","author":"Sridar","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.yrtph.2016.01.004_bib34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejps.2014.07.009","article-title":"Human and simulated intestinal fluids as solvent systems to explore effects on intestinal solubility and permeability","volume":"63","author":"Stappaerts","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.yrtph.2016.01.004_bib35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/03602530903491881","article-title":"Sandwich-cultured hepatocytes: an in\u00a0vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity","volume":"42","author":"Swift","year":"2010","journal-title":"Drug. Metab. Rev."},{"key":"10.1016\/j.yrtph.2016.01.004_bib36","series-title":"Guidance for Industry: Drug Interaction Studies \u2013 Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations","first-page":"1","author":"U.S. DHHS\/FDA\/CDER","year":"2012"},{"key":"10.1016\/j.yrtph.2016.01.004_bib37","series-title":"Health, United States, 2014: with Special Feature on Adults Aged 55\u201364","author":"U.S. Centers of Disease Control and Prevention (US CDC) Health","year":"2014"},{"issue":"2","key":"10.1016\/j.yrtph.2016.01.004_bib38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pharmthera.2012.08.001","article-title":"Mechanisms underlying food-drug interactions: Inhibition of intestinal metabolism and transport","volume":"136","author":"Won","year":"2012","journal-title":"Pharmacol. Ther."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230016300046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230016300046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T04:25:19Z","timestamp":1537071919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230016300046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":38,"alternative-id":["S0273230016300046"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2016.01.004","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing Natural Product\u2013Drug Interactions: An End-to-End Safety Framework","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}